Shortfall in Phase-III Covaxin trial target, can delay rollout: AIIMS doctor
India | Dec 18, 2020, 01:49 PM ISTThe rollout of Covid-19 vaccine by Bharat Biotech for the general public may get delayed as the All India Institute of Medical Sciences (AIIMS), where its Phase-III human clinical trial is underway, is struggling to find takers of the trial shots, the official heading the project told IANS.